Hrt Financial LP Ampio Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $14,055 - $3.69 Million	-175,699 Reduced 87.99%	23,980 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.16 - $0.47 $31,948 - $93,849	199,679 New	199,679 $33,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $775,274 - $984,002	-496,971 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $675,880 - $1.24 Million	496,971 New	496,971 $839,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.